Abstract: The present invention provides 3 substituted pyridazine compound of formula (I) which are therapeutically useful as SMARCA2 and/or SMARCA4 degraders. These compounds are useful in the treatment and/or prevention of diseases or disorders dependent upon SMARCA2 and/or SMARCA4 in a subject. The present invention also provides preparation of the compounds and pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt or a stereoisomer or a tautomer thereof.
| # | Name | Date |
|---|---|---|
| 1 | 202447066226-PRIORITY DOCUMENTS [02-09-2024(online)].pdf | 2024-09-02 |
| 2 | 202447066226-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [02-09-2024(online)].pdf | 2024-09-02 |
| 3 | 202447066226-FORM 1 [02-09-2024(online)].pdf | 2024-09-02 |
| 4 | 202447066226-COMPLETE SPECIFICATION [02-09-2024(online)].pdf | 2024-09-02 |
| 5 | 202447066226-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [02-09-2024(online)].pdf | 2024-09-02 |
| 6 | 202447066226-FORM-5 [03-09-2024(online)].pdf | 2024-09-03 |
| 7 | 202447066226-FORM 3 [03-09-2024(online)].pdf | 2024-09-03 |
| 8 | 202447066226-FORM 18 [03-09-2024(online)].pdf | 2024-09-03 |
| 9 | 202447066226-Proof of Right [27-11-2024(online)].pdf | 2024-11-27 |
| 10 | 202447066226-FORM 3 [09-12-2024(online)].pdf | 2024-12-09 |